Banco Santander S.A. Has $36.62 Million Stake in Intuitive Surgical, Inc. $ISRG

Banco Santander S.A. increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 18.1% in the second quarter, according to its most recent 13F filing with the SEC. The firm owned 67,396 shares of the medical equipment provider’s stock after purchasing an additional 10,333 shares during the period. Banco Santander S.A.’s holdings in Intuitive Surgical were worth $36,624,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its stake in Intuitive Surgical by 1.4% in the 1st quarter. Vanguard Group Inc. now owns 32,665,531 shares of the medical equipment provider’s stock worth $16,178,258,000 after purchasing an additional 453,335 shares during the period. Invesco Ltd. boosted its stake in Intuitive Surgical by 1.7% in the 1st quarter. Invesco Ltd. now owns 4,219,974 shares of the medical equipment provider’s stock worth $2,090,027,000 after purchasing an additional 71,794 shares during the period. Northern Trust Corp boosted its stake in Intuitive Surgical by 0.3% in the 1st quarter. Northern Trust Corp now owns 3,631,281 shares of the medical equipment provider’s stock worth $1,798,465,000 after purchasing an additional 11,988 shares during the period. Wellington Management Group LLP boosted its stake in Intuitive Surgical by 15.0% in the 1st quarter. Wellington Management Group LLP now owns 3,499,052 shares of the medical equipment provider’s stock worth $1,732,975,000 after purchasing an additional 457,080 shares during the period. Finally, Nuveen LLC acquired a new position in Intuitive Surgical in the 1st quarter worth approximately $1,715,899,000. Institutional investors and hedge funds own 83.64% of the company’s stock.

Analysts Set New Price Targets

A number of equities analysts recently commented on the stock. Zacks Research lowered shares of Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, August 20th. Sanford C. Bernstein reissued an “outperform” rating and set a $685.00 target price on shares of Intuitive Surgical in a research note on Tuesday, October 21st. Erste Group Bank reissued a “hold” rating on shares of Intuitive Surgical in a research note on Wednesday, July 23rd. HSBC lifted their target price on shares of Intuitive Surgical from $595.00 to $644.00 and gave the company a “buy” rating in a research note on Thursday. Finally, Jefferies Financial Group lifted their target price on shares of Intuitive Surgical from $550.00 to $560.00 and gave the company a “hold” rating in a research note on Wednesday, October 22nd. One investment analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. According to data from MarketBeat, Intuitive Surgical presently has a consensus rating of “Moderate Buy” and a consensus price target of $602.32.

Insider Buying and Selling at Intuitive Surgical

In related news, Director Amy L. Ladd sold 335 shares of Intuitive Surgical stock in a transaction on Thursday, September 4th. The shares were sold at an average price of $440.69, for a total value of $147,631.15. Following the completion of the sale, the director owned 739 shares of the company’s stock, valued at approximately $325,669.91. The trade was a 31.19% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, insider Gary S. Guthart sold 29,360 shares of Intuitive Surgical stock in a transaction on Friday, August 29th. The shares were sold at an average price of $472.49, for a total transaction of $13,872,306.40. Following the completion of the sale, the insider directly owned 19,827 shares of the company’s stock, valued at approximately $9,368,059.23. The trade was a 59.69% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders sold 30,031 shares of company stock valued at $14,177,895. 0.70% of the stock is owned by company insiders.

Intuitive Surgical Trading Down 0.9%

ISRG stock opened at $546.51 on Monday. Intuitive Surgical, Inc. has a 1 year low of $425.00 and a 1 year high of $616.00. The company has a fifty day simple moving average of $458.09 and a 200 day simple moving average of $497.11. The firm has a market cap of $195.91 billion, a PE ratio of 72.29, a PEG ratio of 5.02 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The business had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. During the same quarter in the previous year, the business earned $1.84 EPS. Intuitive Surgical’s quarterly revenue was up 22.9% compared to the same quarter last year. As a group, analysts forecast that Intuitive Surgical, Inc. will post 6.43 EPS for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.